Orbital atherectomy for hardened leg arteries in chronic limb-threatening ischemia
Follows 250 people with chronic limb-threatening ischemia treated with orbital atherectomy.
Key facts
- Who runs it
- Cardiovascular and Interventional Radiological Society of Europe
- Where
- Hull, United KingdomSee the site
- Trial code
- Registry title
- ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 31 Aug 2026
- Expected to end
- Dec 2031
- Type of study
- Observational
- Treatments tested
- Stealth 360™ Peripheral Orbital Atherectomy System from Abbott
- Record updated
- 23 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic limb-threatening ischemia, a severe lack of blood flow to the leg. They must have hard, calcium-filled arteries in the thigh or lower leg that will be treated with the Stealth 360 orbital atherectomy device.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Rutherford category 4 or higher. Calcified narrowings in the femoropopliteal or infrapopliteal arteries, visible on fluoroscopy or CT-angiography.
- Earlier treatment
- No endovascular procedure (treatment from inside the blood vessel) on the treatment site within 4 weeks before the study procedure.
Main reasons for not taking part
- Pregnant or breastfeeding women, minors, and people who cannot give consent freely
- Poor blood flow into the treated area (more than 30% narrowing) after it has been improved
- Fewer than 1 open artery carrying blood below the treated area
- A planned amputation above the ankle on the treated leg
- Taking part in the RESCUE trial (NCT07270575)
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Rutherford classification category ≥4
- Treatment of femoropopliteal or infrapopliteal calcified lesions with OA using the Stealth 360 peripheral OA System
- Calcification of target lesions must be visible on fluoroscopy or CT-angiography
- Patients competent and willing to provide informed consent
Who cannot take part
- Endovascular procedure(s) on the treatment site within 4 weeks before index procedure
- Minors and other vulnerable populations who may not be able to give informed consent freely or for whom participation is not essential to the study (incapacitated and unconscious individuals, persons deprived of liberty, pregnant and breastfeeding women, etc.)
- Inadequate inflow (>30% stenosis) following optimization
- Insufficient direct outflow (less than 1 run-off vessel)
- Patients planned to receive an above ankle amputation of the target limb
- Patients enrolled in RESCUE (ClinicalTrials.gov ID NCT07270575)
Where in United Kingdom
- Hull University Teaching Hospitals NHS TrustHull, United KingdomContact: Raghu Lakshminarayan, Dr (principal investigator)Taking people
About the trial
What the trial wants to find out
ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.
The group in the trial
- Adult CLTI patients with femoropopliteal or infrapopliteal calcified lesions
Eligible patients are those who will undergo OA prior to any adjunctive endovascular procedure
Treatment: Stealth 360™ Peripheral Orbital Atherectomy System from Abbott
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
- Plain-language title
- Orbital atherectomy for hardened leg arteries in chronic limb-threatening ischemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 23 September 2026